First Trust Nasdaq Pharmaceuticals ETF
Limited financial coverage for FTXH.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
- IPO
- 2016
- HQ
- Wheaton, IL, US
Get TickerSpark's AI analysis on FTXH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.02B
- Div Yield
- 0.70%
- 52W High
- $43.52
- 52W Low
- $28.77
- 50D MA
- $40.90
- 200D MA
- $36.47
- Beta
- 0.46
- RSI (14)
- 53
- Avg Volume
- 681.63K
No earnings-call transcripts are available for FTXH yet.
- Free Float
- 100.0%
- Shares Outstanding
- 24.75M
- Float Shares
- 24.75M
of shares held by institutions
32 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Lpl Financial LLC | 151.47K | ▼ 26.16K |
| Oppenheimer & Co Inc | 114.18K | ▲ 73.63K |
| Raymond James Financial Inc | 54.97K | ▲ 43.25K |
| Truist Financial Corp | 52.13K | ▼ 4.96K |
| Marshall Investment Management, LLC | 38.08K | ▼ 7.15K |
| Ameritas Investment Partners, Inc. | 33.99K | ▲ 3.92K |
| Cambridge Investment Research Advisors, Inc. | 30.52K | ▲ 10.98K |
| Nilsine Partners, LLC | 28.06K | ▲ 937 |
| Royal Bank Of Canada | 14.32K | ▲ 14.27K |
| Goldman Sachs Group Inc | 13.73K | ▼ 5.62K |
| Vivaldi Capital Management LP | 12.59K | ▲ 1.74K |
| Commonwealth Equity Services, LLC | 10.73K | ▲ 3.54K |
Held by 2 ETFs
Biggest fund positions in FTXH by dollar value.
Our FTXH coverage
Recent articles, reports, and earnings notes.
No research on FTXH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FTXH report →Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)?
zacks.com · Sep 29
Is First Trust NASDAQ Pharmaceuticals ETF (FTXH) a Strong ETF Right Now?
zacks.com · Aug 6
Should You Invest in the First Trust NASDAQ Pharmaceuticals ETF (FTXH)?
zacks.com · Jul 30
Trump to announce discount drug pricing expansion, White House official says
reuters.com · May 18
Could pressure to make money faster kill the next lifesaving pill?
marketwatch.com · Apr 15
Pharma ETF (FTXH) Hits New 52-Week High
zacks.com · Nov 19
Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1
fastcompany.com · Sep 26
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
zacks.com · Sep 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.